Free tool
Diagnostics stocks
We cover 22 companies grouped under the Diagnostics theme. The median market value in the group is $285.93M. Across the group, the median move over the past trading day is +0.91%. 41% of the 22 with a 200-day average trade above it. Price change over the past year runs from −86.7% to +80.1% across the middle 80 percent of the group, with a median of −13.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
22 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| PSNL | Personalis, Inc. | $17.25 | +43.99% | +119.75% | +267.02% | Nov 3, 2026 |
| DIA.WA | Diagnostyka S.A. | 166.50 PLN | +0.54% | −3.70% | −17.53% | Sep 10, 2026 |
| 4544.T | H.U. Group Holdings, Inc. | 3,678.00 JPY | +5.93% | +9.61% | +11.45% | Nov 11, 2026 |
| OPK | OPKO Health, Inc. | $1.49 | +20.16% | +17.32% | +7.19% | Oct 28, 2026 |
| QDEL | QuidelOrtho Corporation | $15.05 | −10.58% | −47.71% | −45.57% | Nov 5, 2026 |
| 4694.T | BML, Inc. | 3,670.00 JPY | +1.66% | −2.27% | +7.64% | Nov 6, 2026 |
| CEVI.ST | CellaVision AB (publ) | 167.40 SEK | +15.93% | +13.18% | −3.32% | Oct 28, 2026 |
| NIOX.L | NIOX Group Plc | 68.00 GBP | +11.48% | +0.03% | −6.05% | Sep 29, 2026 |
| 0KCC.L | Insight Molecular Diagnostics Inc. | $4.42 | +2.67% | −36.40% | +80.26% | Nov 9, 2026 |
| SBS.DE | Stratec SE | 22.35 EUR | +7.97% | +1.13% | −16.29% | Nov 12, 2026 |
| BDSX | Biodesix, Inc. | $28.08 | +26.35% | +334.60% | +186.48% | Nov 3, 2026 |
| 0RAR.L | Stratec SE | 23.05 EUR | +2.67% | +4.06% | −13.37% | Nov 12, 2026 |
| OSUR | OraSure Technologies, Inc. | $3.78 | −4.55% | +58.82% | +20.38% | Nov 4, 2026 |
| LUCD | Lucid Diagnostics Inc. | $1.01 | +11.85% | −9.82% | −12.93% | Nov 11, 2026 |
| IMDX | Insight Molecular Diagnostics Inc. | $4.44 | −5.53% | −37.99% | +78.31% | Nov 9, 2026 |
| SERA | Sera Prognostics, Inc. | $2.18 | +6.34% | −27.33% | −17.42% | Nov 16, 2026 |
| MDXH | MDxHealth SA | $0.79 | +88.71% | −77.00% | −83.84% | Nov 12, 2026 |
| PAVM | PAVmed Inc. | $5.28 | +1.44% | −28.04% | −64.04% | Nov 12, 2026 |
| CODX | Co-Diagnostics, Inc. | $1.23 | −39.71% | −77.88% | −87.07% | Nov 16, 2026 |
| CDIO | Cardio Diagnostics Holdings, Inc. | $1.91 | +17.90% | −32.75% | −45.58% | Nov 6, 2026 |
| VNRX | VolitionRx Limited | $0.38 | −56.30% | −92.88% | −97.21% | Nov 12, 2026 |
| REVB | Revelation Biosciences, Inc. | $1.00 | −5.66% | −69.25% | −91.21% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.